As of June 20, 2025, Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (002864.SZ) reports a Gross Margin of 60.80%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's Gross Margin
Over recent years, Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's Gross Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2024-12-31 | 60.80% |
| 2023-12-31 | 57.81% |
| 2022-12-31 | 58.10% |
| 2021-12-31 | 58.27% |
| 2020-12-31 | 61.88% |
This slight downward trend highlights how Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd manages its operational efficiency and pricing power over time.
Comparing Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's Gross Margin to Peers
To better understand Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (002864.SZ) | 60.80% |
| Jilin Province Huinan Changlong Bio-pharmacy Co Ltd (8049.HK) | 82.22% |
| Nanjing Hicin Pharmaceutical Co Ltd (300584.SZ) | 81.55% |
| Ginwa Enterprise Group Inc (600080.SS) | 78.30% |
| Hunan Hansen Pharmaceutical Co Ltd (002412.SZ) | 75.84% |
| Jilin Jian Yisheng Pharmaceutical Co Ltd (002566.SZ) | 74.23% |
Compared to its competitors, Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.